This brand name is authorized in Brazil, Ecuador, Singapore, South Africa.
The drug ZOBONE contains one active pharmaceutical ingredient (API):
1
|
UNII
70HZ18PH24 - ZOLEDRONIC ACID ANHYDROUS
|
|
Zoledronic acid belongs to the class of bisphosphonates and acts primarily on bone. It is an inhibitor of osteoclastic bone resorption. |
|
Below package inserts are available for further reading:
| Document | Type | Information Source | |
|---|---|---|---|
| ZOBONE Concentrate for solution for infusion | MPI, Generic | Health Products Regulatory Authority (ZA) |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| M05BA08 | Zoledronic acid | M Musculo-skeletal system → M05 Drugs for treatment of bone diseases → M05B Drugs affecting bone structure and mineralization → M05BA Bisphosphonates |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| BR | Câmara de Regulação do Mercado de Medicamentos | 532413070009903 |
| EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | 360-MEE-0614 |
| SG | Health Sciences Authority | 15562P |
| ZA | Health Products Regulatory Authority | 42/34/0664 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.